Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 13121–13140 of 17,529 recalls

June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Alprostadil 40 mcg/ml Injection

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Testosterone 62.5 mg Pellet

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 1, 2015· American Health Packaging

Recalled Item: Zonisamide capsules

The Issue: CGMP Deviations: Firm did not adequately investigate customer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 1, 2015· American Health Packaging

Recalled Item: Amlodipine besylate tablets

The Issue: CGMP Deviations: Firm did not adequately investigate customer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 1, 2015· American Health Packaging

Recalled Item: Amlodipine besylate tablets

The Issue: CGMP Deviations: Firm did not adequately investigate customer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 1, 2015· American Health Packaging

Recalled Item: Lisinopril tablets

The Issue: CGMP Deviations: Firm did not adequately investigate customer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 1, 2015· American Health Packaging

Recalled Item: Azithromycin tablets

The Issue: CGMP Deviations: Firm did not adequately investigate customer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 1, 2015· American Health Packaging

Recalled Item: Azithromycin tablets

The Issue: CGMP Deviations: Firm did not adequately investigate customer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 1, 2015· American Health Packaging

Recalled Item: Clarithromycin tablets

The Issue: CGMP Deviations: Firm did not adequately investigate customer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 1, 2015· American Health Packaging

Recalled Item: Amlodipine besylate tablets

The Issue: CGMP Deviations: Firm did not adequately investigate customer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 1, 2015· American Health Packaging

Recalled Item: Lisinopril tablets

The Issue: CGMP Deviations: Firm did not adequately investigate customer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 1, 2015· American Health Packaging

Recalled Item: Famotidine tablets

The Issue: CGMP Deviations: Firm did not adequately investigate customer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 1, 2015· American Health Packaging

Recalled Item: Lisinopril tablets

The Issue: CGMP Deviations: Firm did not adequately investigate customer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 1, 2015· American Health Packaging

Recalled Item: Azithromycin tablets

The Issue: CGMP Deviations: Firm did not adequately investigate customer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 1, 2015· American Health Packaging

Recalled Item: Lisinopril tablets

The Issue: CGMP Deviations: Firm did not adequately investigate customer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 29, 2015· Apotex Inc.

Recalled Item: Losartan potassium tablets USP

The Issue: Failed Content Uniformity Specifications: The product may not

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 29, 2015· Apotex Inc.

Recalled Item: Losartan potassium tablets USP

The Issue: Failed Content Uniformity Specifications: The product may not

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 29, 2015· Apotex Inc.

Recalled Item: Enalapril maleate and hydrochlorothiazide tablets USP

The Issue: Failed Content Uniformity Specifications: The product may not

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 29, 2015· Apotex Inc.

Recalled Item: Losartan potassium tablets USP

The Issue: Failed Content Uniformity Specifications: The product may not

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 28, 2015· Lincare, Inc.

Recalled Item: TPN 3:1

The Issue: Lack of Assurance of Sterility: Sterility of product

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund